Latest Delcath Systems News & Updates

See the latest news and media coverage for Delcath. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Delcath Systems (Delcath)

Interventional oncology company focused on liver cancer treatments

delcath.com
Headquarters
New York, United States
Founded year
1987
Company type
Public company
Number of employees
150–200

Last updated

Latest news about Delcath Systems (Delcath)

In short: Delcath reported strong Q2 2026 revenue growth and raised its full-year guidance to $104-$108 million amid HEPZATO procedure expansion.

Company announcements

Delcath

Delcath Systems announces CHEMOSAT inclusion in ESMO–EURACAN guidelines

CHEMOSAT Hepatic Delivery System for Melphalan is recommended as a liver-directed therapy for uveal melanoma with liver metastases. It supports improved survival from Phase 3 trials.

Unlock all announcements with a

Media coverage

Yahoo Finance

Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates

Delcath Systems (DCTH) delivered earnings and revenue surprises of +143.75% and +15.88%,...

Unlock all articles with a

Never miss news about Delcath

Track Delcath and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.